The Centers for Medicare & Medicaid Services (CMS) has submitted to the Office of Management and Budget (OMB) the proposed rulemaking for Stage 3 meaningful use, which is the next stage of compliance for eligible professionals and hospitals in the Electronic Health Records (EHR) Incentive Program.  Stage 3 is scheduled to begin in 2017.

The public notice provides little insight into the substance of the proposed rule.  However, the notice previews that “Stage 3 will focus on improving health care outcomes and further advance interoperability.”  It also explains that CMS plans to “propose changes to the reporting period, timelines, and structure of the [EHR Incentive Program], including providing a single definition of meaningful use,” in order to “provide a flexible, yet, clearer framework to ensure future sustainability of the EHR program and reduce confusion stemming from multiple stage requirements.”  The date of publication of the proposed rule is still unknown, but the notice indicates that it is planned for some time in 2015.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Covington Digital Health Team

Stakeholders across the healthcare, technology and communications industries seek to harness the power of data and information technology to improve the effectiveness and efficiency of their products, solutions and services, create new and cutting-edge innovations, and achieve better outcomes for patients. Partnering with…

Stakeholders across the healthcare, technology and communications industries seek to harness the power of data and information technology to improve the effectiveness and efficiency of their products, solutions and services, create new and cutting-edge innovations, and achieve better outcomes for patients. Partnering with lawyers who understand how the regulatory, IP, and commercial pieces of the digital health puzzle fit together is essential. Covington offers unsurpassed breadth and depth of expertise and experience concerning the legal, regulatory, and policy issues that affect digital health products and services. To learn more, click here.